INOVIO to Present at Upcoming Scientific Conference

Group 1 - INOVIO is a biotechnology company focused on developing and commercializing DNA medicines for HPV-related diseases, cancer, and infectious diseases [2] - The company will present at the World Congress of Electroporation on September 18, 2024, with an oral presentation by Trevor Smith, VP of Preclinical R&D [1] - The presentation will cover the development of in vivo-launched synthetic DNA-encoded antibodies using CELLECTRA® electroporation technology [1] Group 2 - The abstract from the conference will be available on INOVIO's website after the presentation [1] - INOVIO's technology aims to optimize the design and delivery of innovative DNA medicines that enable the body to produce its own disease-fighting tools [2]